Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Menu Back to Regulatory-Strategy

Regulatory Strategy

This track explores the various aspects relating to the European Regulatory Network Strategy. It looks at novel therapies coming to the market, building further capabilities in regulatory science, ongoing developments in biosimilars, development support and the future of evidence as it relates to regulatory approvals.

Who is This Track Designed For?

Professionals involved in regulatory strategy, regulatory policy and intelligence, market access and HTA policy, project management, academics and consultants.

Back to DIA Europe 2021

Back to

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.